 Jeffrey SooHoo
Concepts (162)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glaucoma | 18 | 2025 | 219 | 3.990 |
Why?
| | Intraocular Pressure | 26 | 2025 | 297 | 2.530 |
Why?
| | Angiogenesis Inhibitors | 4 | 2018 | 220 | 1.710 |
Why?
| | Phacoemulsification | 11 | 2025 | 115 | 1.700 |
Why?
| | Trabeculectomy | 10 | 2025 | 71 | 1.680 |
Why?
| | Glaucoma Drainage Implants | 5 | 2021 | 46 | 1.510 |
Why?
| | Glaucoma, Open-Angle | 8 | 2023 | 101 | 1.440 |
Why?
| | Filtering Surgery | 5 | 2016 | 22 | 1.220 |
Why?
| | Glaucoma, Neovascular | 2 | 2015 | 10 | 0.900 |
Why?
| | Trabecular Meshwork | 5 | 2019 | 79 | 0.860 |
Why?
| | Lens Implantation, Intraocular | 4 | 2018 | 59 | 0.820 |
Why?
| | Tonometry, Ocular | 9 | 2021 | 88 | 0.790 |
Why?
| | Microfluidic Analytical Techniques | 2 | 2012 | 73 | 0.670 |
Why?
| | Eye Injuries | 2 | 2021 | 46 | 0.590 |
Why?
| | Vascular Endothelial Growth Factor A | 3 | 2015 | 530 | 0.550 |
Why?
| | Cell Separation | 2 | 2009 | 316 | 0.530 |
Why?
| | Leukocytes | 2 | 2009 | 304 | 0.520 |
Why?
| | Cataract | 6 | 2023 | 208 | 0.510 |
Why?
| | Perception | 1 | 2018 | 340 | 0.490 |
Why?
| | Laser Therapy | 2 | 2016 | 131 | 0.480 |
Why?
| | Antihypertensive Agents | 2 | 2016 | 485 | 0.480 |
Why?
| | Receptors, Vascular Endothelial Growth Factor | 1 | 2015 | 107 | 0.470 |
Why?
| | Prosthesis Design | 1 | 2016 | 306 | 0.460 |
Why?
| | Ocular Hypertension | 3 | 2022 | 66 | 0.450 |
Why?
| | Ophthalmologic Surgical Procedures | 1 | 2014 | 57 | 0.450 |
Why?
| | Minimally Invasive Surgical Procedures | 2 | 2015 | 170 | 0.450 |
Why?
| | Blepharoptosis | 1 | 2014 | 8 | 0.440 |
Why?
| | Hyphema | 1 | 2013 | 4 | 0.440 |
Why?
| | Patient Preference | 1 | 2016 | 185 | 0.430 |
Why?
| | Telangiectasis | 1 | 2013 | 6 | 0.430 |
Why?
| | Skin Diseases, Vascular | 1 | 2013 | 9 | 0.420 |
Why?
| | Visual Acuity | 5 | 2019 | 322 | 0.410 |
Why?
| | Laser Coagulation | 4 | 2023 | 57 | 0.410 |
Why?
| | Orbital Neoplasms | 1 | 2012 | 21 | 0.400 |
Why?
| | Fluorescein Angiography | 1 | 2013 | 143 | 0.400 |
Why?
| | Recombinant Fusion Proteins | 1 | 2015 | 643 | 0.390 |
Why?
| | Ophthalmologists | 2 | 2023 | 11 | 0.390 |
Why?
| | Anterior Chamber | 1 | 2012 | 22 | 0.390 |
Why?
| | Conjunctiva | 1 | 2012 | 51 | 0.380 |
Why?
| | Intravitreal Injections | 3 | 2018 | 56 | 0.380 |
Why?
| | Carcinoma | 1 | 2012 | 217 | 0.340 |
Why?
| | Uveitis | 2 | 2022 | 127 | 0.330 |
Why?
| | Stents | 4 | 2021 | 504 | 0.330 |
Why?
| | Dexamethasone | 1 | 2012 | 346 | 0.330 |
Why?
| | Urinary Bladder Neoplasms | 2 | 2012 | 228 | 0.330 |
Why?
| | Blood Component Removal | 1 | 2009 | 26 | 0.310 |
Why?
| | Cataract Extraction | 2 | 2023 | 97 | 0.310 |
Why?
| | Surveys and Questionnaires | 4 | 2023 | 5406 | 0.300 |
Why?
| | Ophthalmic Solutions | 3 | 2018 | 74 | 0.300 |
Why?
| | Humans | 41 | 2025 | 129650 | 0.300 |
Why?
| | Ultrafiltration | 1 | 2007 | 28 | 0.270 |
Why?
| | Ciliary Body | 2 | 2018 | 33 | 0.260 |
Why?
| | Microfluidics | 1 | 2007 | 53 | 0.260 |
Why?
| | Erythrocytes | 1 | 2012 | 672 | 0.260 |
Why?
| | Leukocyte Count | 1 | 2007 | 326 | 0.250 |
Why?
| | Pilocarpine | 1 | 2025 | 15 | 0.240 |
Why?
| | Prosthesis Implantation | 2 | 2018 | 145 | 0.220 |
Why?
| | Endoscopy | 2 | 2018 | 285 | 0.220 |
Why?
| | Negotiating | 1 | 2023 | 30 | 0.210 |
Why?
| | Internship and Residency | 2 | 2023 | 1053 | 0.190 |
Why?
| | Ophthalmology | 1 | 2023 | 82 | 0.190 |
Why?
| | Aged | 12 | 2025 | 22103 | 0.190 |
Why?
| | Weapons | 1 | 2021 | 8 | 0.180 |
Why?
| | Civil Disorders | 1 | 2021 | 7 | 0.180 |
Why?
| | Political Activism | 1 | 2021 | 9 | 0.180 |
Why?
| | Aged, 80 and over | 7 | 2025 | 7086 | 0.170 |
Why?
| | Education, Medical, Graduate | 2 | 2023 | 438 | 0.170 |
Why?
| | Treatment Outcome | 7 | 2025 | 10230 | 0.170 |
Why?
| | Female | 16 | 2025 | 68776 | 0.160 |
Why?
| | Equipment Design | 3 | 2018 | 514 | 0.160 |
Why?
| | Postoperative Period | 4 | 2025 | 329 | 0.160 |
Why?
| | Retrospective Studies | 11 | 2025 | 14518 | 0.150 |
Why?
| | Administration, Topical | 2 | 2016 | 145 | 0.150 |
Why?
| | Male | 16 | 2025 | 63681 | 0.150 |
Why?
| | Uveitis, Anterior | 1 | 2018 | 13 | 0.150 |
Why?
| | Glaucoma, Angle-Closure | 1 | 2018 | 16 | 0.150 |
Why?
| | Equipment Failure Analysis | 2 | 2009 | 131 | 0.140 |
Why?
| | Middle Aged | 10 | 2025 | 31154 | 0.140 |
Why?
| | Adrenergic alpha-1 Receptor Antagonists | 1 | 2016 | 17 | 0.140 |
Why?
| | Acrylic Resins | 1 | 2016 | 44 | 0.130 |
Why?
| | Lenses, Intraocular | 1 | 2016 | 43 | 0.130 |
Why?
| | Cross-Sectional Studies | 4 | 2023 | 5066 | 0.130 |
Why?
| | Infant | 4 | 2014 | 9024 | 0.130 |
Why?
| | Adult | 9 | 2025 | 35576 | 0.130 |
Why?
| | Cadaver | 1 | 2016 | 306 | 0.120 |
Why?
| | Vision Disorders | 1 | 2016 | 135 | 0.120 |
Why?
| | Drug Packaging | 1 | 2015 | 41 | 0.120 |
Why?
| | Blepharoplasty | 1 | 2014 | 8 | 0.110 |
Why?
| | Follow-Up Studies | 2 | 2025 | 4897 | 0.110 |
Why?
| | Oculomotor Muscles | 1 | 2014 | 38 | 0.110 |
Why?
| | Rabbits | 2 | 2012 | 778 | 0.110 |
Why?
| | Eyelids | 1 | 2014 | 34 | 0.110 |
Why?
| | Accidents, Home | 1 | 2013 | 29 | 0.110 |
Why?
| | Livedo Reticularis | 1 | 2013 | 4 | 0.110 |
Why?
| | Delivery of Health Care | 1 | 2020 | 894 | 0.110 |
Why?
| | Iris | 1 | 2013 | 19 | 0.110 |
Why?
| | Prospective Studies | 4 | 2021 | 7133 | 0.100 |
Why?
| | Pilot Projects | 1 | 2018 | 1587 | 0.100 |
Why?
| | Sulfonamides | 1 | 2016 | 496 | 0.100 |
Why?
| | Urothelium | 1 | 2012 | 37 | 0.100 |
Why?
| | Goblet Cells | 1 | 2012 | 18 | 0.100 |
Why?
| | Mitomycin | 1 | 2012 | 32 | 0.100 |
Why?
| | Quaternary Ammonium Compounds | 1 | 2012 | 53 | 0.090 |
Why?
| | Young Adult | 3 | 2019 | 12426 | 0.090 |
Why?
| | Blister | 1 | 2012 | 41 | 0.090 |
Why?
| | Diffusion | 1 | 2012 | 117 | 0.090 |
Why?
| | Fatal Outcome | 1 | 2012 | 300 | 0.090 |
Why?
| | Neovascularization, Pathologic | 1 | 2013 | 297 | 0.090 |
Why?
| | Delayed-Action Preparations | 1 | 2012 | 173 | 0.090 |
Why?
| | Medication Adherence | 1 | 2015 | 558 | 0.090 |
Why?
| | Hemolysis | 1 | 2012 | 199 | 0.090 |
Why?
| | Collagen | 1 | 2012 | 434 | 0.080 |
Why?
| | Adolescent | 4 | 2019 | 20393 | 0.080 |
Why?
| | Wound Healing | 1 | 2012 | 306 | 0.080 |
Why?
| | Postoperative Complications | 1 | 2021 | 2483 | 0.080 |
Why?
| | Phase Transition | 1 | 2009 | 24 | 0.080 |
Why?
| | Kinetics | 1 | 2012 | 1642 | 0.070 |
Why?
| | Postoperative Care | 2 | 2025 | 241 | 0.070 |
Why?
| | Inflammation | 1 | 2018 | 2736 | 0.070 |
Why?
| | Incidence | 1 | 2013 | 2644 | 0.070 |
Why?
| | Sex Factors | 2 | 2023 | 1968 | 0.060 |
Why?
| | Miotics | 1 | 2025 | 6 | 0.060 |
Why?
| | Muscarinic Agonists | 1 | 2025 | 16 | 0.060 |
Why?
| | Risk Assessment | 1 | 2014 | 3240 | 0.060 |
Why?
| | Colorado | 1 | 2013 | 4421 | 0.050 |
Why?
| | Infant, Newborn | 2 | 2014 | 5762 | 0.050 |
Why?
| | Salaries and Fringe Benefits | 1 | 2023 | 55 | 0.050 |
Why?
| | Tomography, X-Ray Computed | 1 | 2012 | 2535 | 0.050 |
Why?
| | Dissent and Disputes | 1 | 2021 | 17 | 0.040 |
Why?
| | Crowding | 1 | 2021 | 35 | 0.040 |
Why?
| | Child, Preschool | 2 | 2013 | 10517 | 0.040 |
Why?
| | Circadian Rhythm | 1 | 2023 | 413 | 0.040 |
Why?
| | Cells, Cultured | 1 | 2007 | 4083 | 0.040 |
Why?
| | Preoperative Period | 1 | 2019 | 115 | 0.040 |
Why?
| | Health Surveys | 1 | 2021 | 494 | 0.040 |
Why?
| | Axial Length, Eye | 1 | 2018 | 15 | 0.040 |
Why?
| | Exfoliation Syndrome | 1 | 2018 | 10 | 0.040 |
Why?
| | Corneal Pachymetry | 1 | 2018 | 15 | 0.040 |
Why?
| | Pseudophakia | 1 | 2018 | 11 | 0.040 |
Why?
| | Educational Status | 1 | 2020 | 470 | 0.040 |
Why?
| | Histological Techniques | 1 | 2018 | 40 | 0.040 |
Why?
| | Refraction, Ocular | 1 | 2018 | 36 | 0.040 |
Why?
| | Sleep | 1 | 2023 | 685 | 0.030 |
Why?
| | Microscopy | 1 | 2018 | 141 | 0.030 |
Why?
| | Curriculum | 1 | 2023 | 917 | 0.030 |
Why?
| | Clinical Competence | 1 | 2023 | 1017 | 0.030 |
Why?
| | Fibrosis | 1 | 2018 | 520 | 0.030 |
Why?
| | Lasers, Semiconductor | 1 | 2015 | 12 | 0.030 |
Why?
| | United States | 2 | 2023 | 13903 | 0.030 |
Why?
| | Child | 2 | 2013 | 20883 | 0.030 |
Why?
| | Medication Errors | 1 | 2015 | 95 | 0.030 |
Why?
| | Monitoring, Physiologic | 1 | 2016 | 268 | 0.030 |
Why?
| | Animals | 2 | 2012 | 35361 | 0.030 |
Why?
| | Tissue Donors | 1 | 2012 | 391 | 0.020 |
Why?
| | Neoplasms | 1 | 1975 | 2470 | 0.010 |
Why?
| | Emigration and Immigration | 1 | 1975 | 50 | 0.010 |
Why?
| | Mexico | 1 | 1975 | 190 | 0.010 |
Why?
| | California | 1 | 1975 | 401 | 0.010 |
Why?
| | Risk | 1 | 1975 | 854 | 0.010 |
Why?
| | Uterine Cervical Neoplasms | 1 | 1975 | 233 | 0.010 |
Why?
| | Breast Neoplasms | 1 | 1975 | 2142 | 0.000 |
Why?
| | Lung Neoplasms | 1 | 1975 | 2344 | 0.000 |
Why?
|
|
SooHoo's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|